Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.30 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.85 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.571NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.55 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.239NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.574NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.21 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.619.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.12.1 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.260NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.456NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.16 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.374NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.63 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.298NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used